Impact of iron and erythropoiesis-stimulating agent dose on mortality of hemodialysis patients with cancer. Michon-Colin A, Lombardi Y, Seret G, Lavainne F, et al. J Nephrol 2024 Dec 15. doi: 10.1007/s40620-024-02162.

Read + Share

Amedeo Smart

Independent Medical Education

Michon-Colin A, Lombardi Y, Seret G, Lavainne F, et al. Impact of iron and erythropoiesis-stimulating agent dose on mortality of hemodialysis patients with cancer. J Nephrol 2024 Dec 15. doi: 10.1007/s40620-024-02162.
PMID: 39674977